Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat2
|
ENSMUSG00000040033.9 | signal transducer and activator of transcription 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Stat2 | chr10_128280968_128281311 | 509 | 0.546071 | 0.40 | 2.2e-03 | Click! |
Stat2 | chr10_128270361_128270548 | 105 | 0.898442 | 0.39 | 3.7e-03 | Click! |
Stat2 | chr10_128270060_128270342 | 358 | 0.661735 | 0.37 | 5.5e-03 | Click! |
Stat2 | chr10_128270658_128271026 | 266 | 0.768526 | 0.23 | 9.0e-02 | Click! |
Stat2 | chr10_128290612_128290763 | 6580 | 0.070180 | -0.13 | 3.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_103434110_103434336 | 30.31 |
Ifi27 |
interferon, alpha-inducible protein 27 |
11 |
0.95 |
chr4_100994668_100995090 | 21.26 |
Cachd1 |
cache domain containing 1 |
169 |
0.95 |
chr12_26460219_26460410 | 18.39 |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
3862 |
0.17 |
chr7_104446060_104446225 | 17.48 |
Trim30a |
tripartite motif-containing 30A |
19051 |
0.09 |
chr7_104507813_104508003 | 17.45 |
Trim30d |
tripartite motif-containing 30D |
59 |
0.94 |
chr9_65554974_65555491 | 17.40 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
6932 |
0.14 |
chr19_8518374_8518525 | 17.26 |
Gm8189 |
predicted gene 8189 |
23349 |
0.14 |
chr11_86581594_86581768 | 17.17 |
Mir21a |
microRNA 21a |
2477 |
0.22 |
chr11_119392977_119393557 | 16.59 |
Rnf213 |
ring finger protein 213 |
167 |
0.93 |
chr11_88999276_88999500 | 16.39 |
Trim25 |
tripartite motif-containing 25 |
12 |
0.96 |
chr6_38342333_38342771 | 15.97 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
11721 |
0.13 |
chr11_87725724_87726211 | 15.80 |
Rnf43 |
ring finger protein 43 |
1459 |
0.24 |
chr1_34389196_34389610 | 15.42 |
Gm5266 |
predicted gene 5266 |
22032 |
0.09 |
chr11_78984796_78985130 | 15.27 |
Lgals9 |
lectin, galactose binding, soluble 9 |
17 |
0.98 |
chr5_76990916_76991084 | 15.25 |
Srp72 |
signal recognition particle 72 |
2993 |
0.16 |
chr2_39325768_39325929 | 15.11 |
Vmn2r-ps2 |
vomeronasal 2, receptor, pseudogene 2 |
51742 |
0.11 |
chr19_4046540_4046699 | 14.91 |
Gstp2 |
glutathione S-transferase, pi 2 |
596 |
0.45 |
chr7_104465078_104465376 | 14.80 |
Trim30a |
tripartite motif-containing 30A |
34 |
0.95 |
chr11_53796522_53796874 | 14.72 |
Gm12216 |
predicted gene 12216 |
823 |
0.49 |
chr2_158159962_158160168 | 14.61 |
Tgm2 |
transglutaminase 2, C polypeptide |
13629 |
0.14 |
chr14_14351950_14353283 | 14.36 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr7_141010676_141010885 | 14.06 |
Ifitm3 |
interferon induced transmembrane protein 3 |
10 |
0.94 |
chr17_36121540_36121726 | 14.06 |
Gm19684 |
predicted gene, 19684 |
45 |
0.63 |
chr11_58214634_58215080 | 13.91 |
Irgm2 |
immunity-related GTPase family M member 2 |
151 |
0.92 |
chr2_131213938_131214219 | 13.57 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
3474 |
0.13 |
chr3_59228822_59228973 | 13.19 |
P2ry12 |
purinergic receptor P2Y, G-protein coupled 12 |
1316 |
0.36 |
chr5_36726254_36726643 | 13.11 |
Gm43701 |
predicted gene 43701 |
22170 |
0.11 |
chr13_59820217_59820403 | 13.06 |
Tut7 |
terminal uridylyl transferase 7 |
2278 |
0.17 |
chr12_86836762_86837069 | 12.89 |
Gm10095 |
predicted gene 10095 |
9552 |
0.19 |
chr4_6452560_6452756 | 12.71 |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
921 |
0.61 |
chr4_135312755_135313155 | 12.63 |
Gm12982 |
predicted gene 12982 |
4985 |
0.13 |
chr12_110498667_110498909 | 12.60 |
Gm19605 |
predicted gene, 19605 |
12580 |
0.16 |
chr5_100636931_100637107 | 12.42 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
27400 |
0.12 |
chr10_30655839_30656049 | 11.75 |
Ncoa7 |
nuclear receptor coactivator 7 |
77 |
0.96 |
chr5_99669969_99670445 | 11.71 |
Gm16226 |
predicted gene 16226 |
12203 |
0.14 |
chr17_36042796_36043034 | 11.62 |
Gm6034 |
predicted gene 6034 |
46 |
0.63 |
chr19_34445758_34445910 | 11.49 |
Gm26902 |
predicted gene, 26902 |
28974 |
0.12 |
chr15_76119070_76119502 | 11.29 |
Eppk1 |
epiplakin 1 |
909 |
0.34 |
chr2_155541250_155541401 | 11.27 |
Mipep-ps |
mitochondrial intermediate peptidase, pseudogene |
1322 |
0.24 |
chr6_34863037_34863250 | 11.24 |
Tmem140 |
transmembrane protein 140 |
3 |
0.96 |
chr17_29444007_29444198 | 11.15 |
Gm36199 |
predicted gene, 36199 |
1803 |
0.23 |
chr17_78882495_78882691 | 10.96 |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
20 |
0.96 |
chr9_107975396_107975585 | 10.82 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
15 |
0.92 |
chr8_33885102_33885274 | 10.77 |
Gm26978 |
predicted gene, 26978 |
559 |
0.74 |
chr9_64070545_64070750 | 10.75 |
Scarletltr |
Scarletltr, erythroid developmental long intergenic non-protein coding transcript |
10114 |
0.12 |
chr4_46410334_46410645 | 10.64 |
Hemgn |
hemogen |
3017 |
0.18 |
chr11_58199487_58199685 | 10.61 |
Igtp |
interferon gamma induced GTPase |
0 |
0.5 |
chr17_33919383_33920010 | 10.58 |
Tapbp |
TAP binding protein |
59 |
0.83 |
chr2_30463478_30464399 | 10.56 |
Ier5l |
immediate early response 5-like |
10281 |
0.13 |
chr19_23152302_23152649 | 10.42 |
Mir1192 |
microRNA 1192 |
3044 |
0.22 |
chr2_25115482_25115813 | 10.35 |
AL732309.1 |
exonuclease 3'-5' domain containing 3 (EXD3) pseudogene |
634 |
0.5 |
chr14_59365472_59365623 | 10.35 |
Phf11d |
PHD finger protein 11D |
77 |
0.96 |
chr3_37553534_37553697 | 10.31 |
Gm12564 |
predicted gene 12564 |
2888 |
0.19 |
chr3_137968882_137969042 | 10.31 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12568 |
0.12 |
chr19_18692041_18692250 | 10.23 |
Carnmt1 |
carnosine N-methyltransferase 1 |
20816 |
0.13 |
chr6_52486731_52486882 | 10.20 |
1700094M24Rik |
RIKEN cDNA 1700094M24 gene |
5645 |
0.18 |
chr1_42532954_42533261 | 10.16 |
Gm37047 |
predicted gene, 37047 |
41294 |
0.17 |
chrX_101428817_101430172 | 10.14 |
Nono |
non-POU-domain-containing, octamer binding protein |
61 |
0.96 |
chr17_44151504_44151795 | 10.01 |
Clic5 |
chloride intracellular channel 5 |
16881 |
0.22 |
chr6_129230311_129230601 | 9.98 |
2310001H17Rik |
RIKEN cDNA 2310001H17 gene |
3518 |
0.15 |
chr6_38533231_38533979 | 9.89 |
Fmc1 |
formation of mitochondrial complex V assembly factor 1 |
103 |
0.96 |
chr9_53356660_53357108 | 9.88 |
Exph5 |
exophilin 5 |
15695 |
0.16 |
chr19_55866081_55866487 | 9.76 |
Ppnr |
per-pentamer repeat gene |
24612 |
0.2 |
chr15_76243373_76243550 | 9.72 |
Parp10 |
poly (ADP-ribose) polymerase family, member 10 |
20 |
0.93 |
chr14_70057380_70057715 | 9.70 |
Gm33524 |
predicted gene, 33524 |
180 |
0.94 |
chr11_85571179_85571330 | 9.66 |
Bcas3 |
breast carcinoma amplified sequence 3 |
9788 |
0.25 |
chr11_72301460_72301663 | 9.64 |
Xaf1 |
XIAP associated factor 1 |
68 |
0.95 |
chr8_46842729_46842958 | 9.63 |
Gm45481 |
predicted gene 45481 |
8931 |
0.19 |
chr7_75610450_75610921 | 9.55 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
418 |
0.86 |
chr13_100201785_100201950 | 9.51 |
Naip2 |
NLR family, apoptosis inhibitory protein 2 |
94 |
0.96 |
chr17_36023721_36023895 | 9.49 |
H2-T24 |
histocompatibility 2, T region locus 24 |
3248 |
0.08 |
chr3_89730573_89730850 | 9.49 |
Adar |
adenosine deaminase, RNA-specific |
37 |
0.97 |
chr5_114922913_114923574 | 9.39 |
Oasl1 |
2'-5' oligoadenylate synthetase-like 1 |
3 |
0.5 |
chr1_87650856_87651061 | 9.38 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
25281 |
0.15 |
chr15_79892044_79892467 | 9.30 |
Apobec3 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
148 |
0.92 |
chr8_70001121_70001486 | 9.23 |
Gatad2a |
GATA zinc finger domain containing 2A |
4919 |
0.13 |
chr19_29066936_29067376 | 9.19 |
Gm9895 |
predicted gene 9895 |
191 |
0.91 |
chr2_152788848_152789045 | 9.18 |
Gm23802 |
predicted gene, 23802 |
16057 |
0.11 |
chr7_103824705_103825121 | 9.13 |
Hbb-bs |
hemoglobin, beta adult s chain |
2812 |
0.09 |
chr10_95297705_95298060 | 9.13 |
Gm48880 |
predicted gene, 48880 |
16971 |
0.14 |
chr6_121226921_121227072 | 9.10 |
Gm15856 |
predicted gene 15856 |
843 |
0.49 |
chr6_101367243_101367630 | 9.04 |
Pdzrn3 |
PDZ domain containing RING finger 3 |
9906 |
0.16 |
chr6_127245874_127246080 | 8.92 |
Gm43635 |
predicted gene 43635 |
8667 |
0.13 |
chr4_135203289_135203476 | 8.91 |
Runx3 |
runt related transcription factor 3 |
48946 |
0.1 |
chr15_74989440_74989591 | 8.90 |
Gm37042 |
predicted gene, 37042 |
765 |
0.35 |
chr13_98944819_98945097 | 8.89 |
Gm35215 |
predicted gene, 35215 |
958 |
0.45 |
chr6_83482581_83482770 | 8.87 |
Dguok |
deoxyguanosine kinase |
4335 |
0.14 |
chr17_21473484_21473684 | 8.81 |
Zfp53 |
zinc finger protein 53 |
15414 |
0.1 |
chr12_69513289_69513503 | 8.72 |
5830428M24Rik |
RIKEN cDNA 5830428M24 gene |
37846 |
0.11 |
chr16_8470935_8471497 | 8.70 |
Mettl22 |
methyltransferase like 22 |
412 |
0.82 |
chr6_121245511_121246024 | 8.69 |
Usp18 |
ubiquitin specific peptidase 18 |
139 |
0.94 |
chr11_108309813_108310102 | 8.68 |
Apoh |
apolipoprotein H |
33397 |
0.16 |
chr2_34783047_34783388 | 8.66 |
Hspa5 |
heat shock protein 5 |
8370 |
0.12 |
chr11_96967275_96967440 | 8.61 |
Sp2 |
Sp2 transcription factor |
1308 |
0.25 |
chr1_157525674_157525866 | 8.58 |
Sec16b |
SEC16 homolog B (S. cerevisiae) |
377 |
0.84 |
chr5_3420545_3420714 | 8.48 |
Cdk6 |
cyclin-dependent kinase 6 |
50320 |
0.1 |
chr7_99411605_99411756 | 8.38 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
2970 |
0.2 |
chr18_5603185_5603788 | 8.34 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
258 |
0.88 |
chr7_141455689_141456231 | 8.23 |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
353 |
0.65 |
chr17_71102620_71102882 | 8.22 |
Myom1 |
myomesin 1 |
16355 |
0.15 |
chr3_135607824_135607975 | 8.21 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
371 |
0.86 |
chr13_93388637_93389177 | 8.20 |
Gm47155 |
predicted gene, 47155 |
21876 |
0.14 |
chr7_99822529_99822695 | 8.14 |
Neu3 |
neuraminidase 3 |
5805 |
0.13 |
chr8_71537587_71537768 | 8.06 |
Bst2 |
bone marrow stromal cell antigen 2 |
221 |
0.82 |
chr13_32924664_32924815 | 8.05 |
Gm11382 |
predicted pseudogene 11382 |
13952 |
0.13 |
chr1_135227711_135228028 | 8.02 |
Gm4204 |
predicted gene 4204 |
4126 |
0.14 |
chr19_4503888_4504039 | 7.91 |
2010003K11Rik |
RIKEN cDNA 2010003K11 gene |
5380 |
0.14 |
chr3_152121980_152122490 | 7.88 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
13713 |
0.13 |
chr5_67551832_67552107 | 7.87 |
1700025A08Rik |
RIKEN cDNA 1700025A08 gene |
55857 |
0.08 |
chr3_108562098_108562631 | 7.87 |
Tmem167b |
transmembrane protein 167B |
102 |
0.92 |
chr10_99467373_99467524 | 7.79 |
Gm35035 |
predicted gene, 35035 |
7218 |
0.16 |
chr10_127508848_127510720 | 7.72 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr1_130741719_130741925 | 7.70 |
Gm28857 |
predicted gene 28857 |
495 |
0.6 |
chr7_128376557_128376708 | 7.70 |
Rgs10 |
regulator of G-protein signalling 10 |
295 |
0.85 |
chr12_26469028_26470065 | 7.69 |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
342 |
0.84 |
chr16_55816469_55816872 | 7.64 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1845 |
0.33 |
chr11_100931708_100931859 | 7.63 |
Stat3 |
signal transducer and activator of transcription 3 |
7597 |
0.15 |
chr8_94735758_94735943 | 7.59 |
Ccl22 |
chemokine (C-C motif) ligand 22 |
9740 |
0.12 |
chr1_133093798_133093949 | 7.49 |
Pik3c2b |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta |
25294 |
0.12 |
chr4_99942066_99942281 | 7.48 |
Itgb3bp |
integrin beta 3 binding protein (beta3-endonexin) |
12360 |
0.17 |
chr11_54542476_54542656 | 7.45 |
Rapgef6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
19620 |
0.19 |
chr8_46844739_46844892 | 7.44 |
Gm45481 |
predicted gene 45481 |
10903 |
0.18 |
chr7_102565432_102565621 | 7.36 |
Trim21 |
tripartite motif-containing 21 |
40 |
0.93 |
chr11_86739069_86739382 | 7.29 |
Cltc |
clathrin, heavy polypeptide (Hc) |
12742 |
0.18 |
chr2_35446870_35447021 | 7.28 |
Ggta1 |
glycoprotein galactosyltransferase alpha 1, 3 |
1112 |
0.4 |
chr12_84969806_84969957 | 7.26 |
Arel1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
943 |
0.35 |
chr7_75826719_75827364 | 7.25 |
Klhl25 |
kelch-like 25 |
21269 |
0.17 |
chr15_95848784_95849032 | 7.22 |
Gm17546 |
predicted gene, 17546 |
18836 |
0.14 |
chr5_92353466_92353617 | 7.21 |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
4652 |
0.11 |
chr11_69846804_69847286 | 7.19 |
Plscr3 |
phospholipid scramblase 3 |
369 |
0.61 |
chr8_40892140_40892296 | 7.12 |
Slc7a2 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
6220 |
0.17 |
chr11_108396201_108396352 | 7.12 |
Apoh |
apolipoprotein H |
983 |
0.51 |
chr16_32190231_32190382 | 7.04 |
Bex6 |
brain expressed family member 6 |
4120 |
0.14 |
chr12_80130626_80131086 | 7.01 |
2310015A10Rik |
RIKEN cDNA 2310015A10 gene |
1740 |
0.26 |
chr1_165717325_165717476 | 7.00 |
Gm37073 |
predicted gene, 37073 |
4156 |
0.12 |
chr18_80372994_80373225 | 6.97 |
Kcng2 |
potassium voltage-gated channel, subfamily G, member 2 |
8855 |
0.15 |
chr1_180261995_180262146 | 6.97 |
Psen2 |
presenilin 2 |
1368 |
0.35 |
chr2_26139656_26141133 | 6.94 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr7_110087753_110088042 | 6.82 |
Zfp143 |
zinc finger protein 143 |
3732 |
0.15 |
chr11_21082805_21082971 | 6.82 |
Peli1 |
pellino 1 |
8403 |
0.2 |
chr4_154635674_154637241 | 6.81 |
Prdm16 |
PR domain containing 16 |
340 |
0.76 |
chr7_135605115_135605302 | 6.75 |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
620 |
0.73 |
chr9_58249475_58249881 | 6.75 |
Pml |
promyelocytic leukemia |
13 |
0.96 |
chr5_120812476_120812687 | 6.71 |
Oas1b |
2'-5' oligoadenylate synthetase 1B |
54 |
0.5 |
chr1_173766916_173767081 | 6.71 |
Ifi204 |
interferon activated gene 204 |
55 |
0.96 |
chr9_114621202_114621360 | 6.71 |
Cnot10 |
CCR4-NOT transcription complex, subunit 10 |
18682 |
0.14 |
chr16_44778878_44779041 | 6.68 |
Cd200r1 |
CD200 receptor 1 |
13133 |
0.13 |
chr5_100643889_100644395 | 6.67 |
Coq2 |
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase |
20277 |
0.13 |
chrX_134636011_134636162 | 6.62 |
Gm7855 |
predicted gene 7855 |
10342 |
0.11 |
chr7_49462552_49462703 | 6.60 |
Gm38059 |
predicted gene, 38059 |
7085 |
0.24 |
chr15_77397415_77397965 | 6.59 |
Apol7a |
apolipoprotein L 7a |
756 |
0.47 |
chr16_95438924_95439075 | 6.58 |
Erg |
ETS transcription factor |
20246 |
0.24 |
chr2_131215601_131215815 | 6.57 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
5104 |
0.11 |
chr5_103760139_103760316 | 6.49 |
Aff1 |
AF4/FMR2 family, member 1 |
5654 |
0.23 |
chr9_72449518_72449701 | 6.41 |
Gm27231 |
predicted gene 27231 |
7830 |
0.08 |
chr8_88362167_88362383 | 6.40 |
Brd7 |
bromodomain containing 7 |
81 |
0.97 |
chr1_156956428_156956586 | 6.39 |
4930439D14Rik |
RIKEN cDNA 4930439D14 gene |
16669 |
0.16 |
chr4_33343002_33343167 | 6.34 |
Rngtt |
RNA guanylyltransferase and 5'-phosphatase |
12070 |
0.19 |
chr7_28593585_28593828 | 6.34 |
Pak4 |
p21 (RAC1) activated kinase 4 |
4380 |
0.1 |
chr6_82763926_82764483 | 6.32 |
Gm17034 |
predicted gene 17034 |
78 |
0.96 |
chr19_34583250_34583593 | 6.32 |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
110 |
0.94 |
chr8_106563693_106563844 | 6.31 |
Gm10073 |
predicted pseudogene 10073 |
9582 |
0.16 |
chr6_38353782_38354731 | 6.29 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
17 |
0.97 |
chr4_135728294_135728497 | 6.26 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
223 |
0.9 |
chr6_5237183_5237334 | 6.26 |
Gm44250 |
predicted gene, 44250 |
16772 |
0.15 |
chr2_167060463_167060614 | 6.26 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
113 |
0.91 |
chr2_84800459_84800621 | 6.25 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
1706 |
0.21 |
chr11_80783625_80783824 | 6.25 |
Myo1d |
myosin ID |
3699 |
0.23 |
chr15_50362191_50362432 | 6.24 |
Gm49198 |
predicted gene, 49198 |
75413 |
0.13 |
chr1_105971738_105972167 | 6.23 |
Gm18801 |
predicted gene, 18801 |
15642 |
0.14 |
chr2_35496015_35496166 | 6.20 |
Gm13445 |
predicted gene 13445 |
4571 |
0.15 |
chr3_137981456_137981683 | 6.18 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
24 |
0.97 |
chr17_40806499_40806942 | 6.16 |
Crisp2 |
cysteine-rich secretory protein 2 |
283 |
0.88 |
chr11_83078101_83078392 | 6.15 |
Gm20234 |
predicted gene, 20234 |
7000 |
0.08 |
chr6_58999004_58999481 | 6.13 |
Fam13a |
family with sequence similarity 13, member A |
25098 |
0.12 |
chr4_141767404_141767762 | 6.11 |
Dnajc16 |
DnaJ heat shock protein family (Hsp40) member C16 |
7070 |
0.13 |
chr6_88821087_88821238 | 6.10 |
Mgll |
monoglyceride lipase |
1968 |
0.2 |
chr19_3322238_3322566 | 6.09 |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
68 |
0.95 |
chr5_114897341_114897492 | 6.09 |
Oasl2 |
2'-5' oligoadenylate synthetase-like 2 |
116 |
0.92 |
chr11_100969129_100969414 | 6.07 |
Cavin1 |
caveolae associated 1 |
1280 |
0.35 |
chr3_96300801_96300952 | 6.06 |
Fcgr1 |
Fc receptor, IgG, high affinity I |
6907 |
0.06 |
chr2_164083755_164083906 | 6.05 |
Stk4 |
serine/threonine kinase 4 |
2233 |
0.21 |
chr3_52618672_52618823 | 6.04 |
Gm10293 |
predicted pseudogene 10293 |
5912 |
0.27 |
chr16_18428507_18428684 | 6.03 |
Txnrd2 |
thioredoxin reductase 2 |
102 |
0.93 |
chr6_97407517_97407674 | 6.01 |
Frmd4b |
FERM domain containing 4B |
10859 |
0.23 |
chr4_147335450_147336299 | 6.00 |
Zfp988 |
zinc finger protein 988 |
3467 |
0.17 |
chr7_78913903_78914305 | 5.99 |
Isg20 |
interferon-stimulated protein |
123 |
0.94 |
chrX_38473528_38474265 | 5.97 |
Gm7598 |
predicted gene 7598 |
2565 |
0.27 |
chr13_96966240_96966404 | 5.97 |
Gm48597 |
predicted gene, 48597 |
15408 |
0.15 |
chr11_77766982_77767146 | 5.93 |
Myo18a |
myosin XVIIIA |
328 |
0.85 |
chr2_158141595_158141856 | 5.93 |
Tgm2 |
transglutaminase 2, C polypeptide |
1989 |
0.27 |
chr18_75464858_75465296 | 5.92 |
Gm10532 |
predicted gene 10532 |
49568 |
0.15 |
chr16_10741207_10741384 | 5.91 |
Socs1 |
suppressor of cytokine signaling 1 |
44241 |
0.07 |
chr4_71291873_71292024 | 5.91 |
Gm11229 |
predicted gene 11229 |
6006 |
0.31 |
chr17_28435004_28435155 | 5.88 |
Fkbp5 |
FK506 binding protein 5 |
5931 |
0.11 |
chr7_127276694_127276979 | 5.88 |
Sephs2 |
selenophosphate synthetase 2 |
2781 |
0.1 |
chr2_181241922_181242214 | 5.87 |
Helz2 |
helicase with zinc finger 2, transcriptional coactivator |
41 |
0.95 |
chr11_75206447_75206598 | 5.83 |
Rtn4rl1 |
reticulon 4 receptor-like 1 |
12739 |
0.1 |
chr2_126597335_126597526 | 5.83 |
Hdc |
histidine decarboxylase |
831 |
0.59 |
chr17_29431849_29432000 | 5.82 |
Gm36199 |
predicted gene, 36199 |
911 |
0.44 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 18.7 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
5.2 | 15.7 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
4.0 | 11.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.3 | 10.0 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
3.2 | 15.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.1 | 9.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
2.8 | 8.5 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
2.5 | 7.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.5 | 9.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.4 | 7.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
2.3 | 16.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
2.3 | 20.8 | GO:0070269 | pyroptosis(GO:0070269) |
2.3 | 41.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
2.3 | 6.8 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
2.2 | 8.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.2 | 6.6 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
2.2 | 8.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
2.0 | 10.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
2.0 | 6.0 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.8 | 5.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.7 | 5.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.6 | 24.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.5 | 4.6 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.5 | 4.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.5 | 1.5 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
1.3 | 33.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.3 | 3.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.2 | 3.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.1 | 3.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 32.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
1.1 | 3.3 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.1 | 8.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.1 | 4.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.1 | 5.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.0 | 2.0 | GO:0021564 | vagus nerve development(GO:0021564) |
1.0 | 4.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
1.0 | 3.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.0 | 7.9 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
1.0 | 21.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.0 | 2.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.0 | 2.9 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.0 | 2.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 2.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.0 | 2.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.9 | 7.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.9 | 5.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.9 | 2.7 | GO:0008228 | opsonization(GO:0008228) |
0.9 | 2.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 2.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.9 | 2.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.9 | 4.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 3.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.8 | 2.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 2.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.8 | 3.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.8 | 3.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.8 | 4.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 2.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.7 | 3.0 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.7 | 2.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 17.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 2.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 1.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.7 | 2.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.6 | 3.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 1.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 5.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 1.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 1.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 4.4 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.6 | 1.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 1.2 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.6 | 1.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 3.0 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.6 | 2.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 4.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.6 | 1.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.6 | 2.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.6 | 3.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 1.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.6 | 2.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 3.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.6 | 6.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.5 | 1.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 1.1 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 1.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 2.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 1.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.5 | 1.6 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.5 | 2.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.5 | 1.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 2.0 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 3.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.5 | 1.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.5 | 1.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.5 | 0.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 2.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.5 | 3.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 0.9 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.5 | 2.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.5 | 1.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 1.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 1.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 2.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 3.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 1.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.3 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.4 | 3.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.4 | 1.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 4.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 1.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 0.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 0.4 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 4.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.4 | 4.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.4 | 1.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 2.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 2.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.4 | 1.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 3.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 1.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 1.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.4 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.4 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 0.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 1.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 8.3 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.4 | 1.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 1.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 2.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.3 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.7 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.3 | 3.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.3 | 2.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 3.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.7 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 2.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 1.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 1.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.7 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.3 | 3.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 1.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 2.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.0 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 1.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.3 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 2.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.6 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.3 | 1.0 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.3 | 0.6 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.3 | 1.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 1.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.3 | 5.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 1.9 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 2.2 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 1.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.9 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 1.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.9 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.3 | 1.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 2.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 2.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 0.3 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.3 | 0.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 3.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 1.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 3.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.6 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.3 | 3.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.9 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 1.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.3 | 7.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.3 | 0.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 1.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 2.8 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.3 | 0.8 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.3 | 1.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.1 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.5 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 0.3 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.3 | 1.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 0.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.8 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.3 | 0.8 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 1.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 6.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 1.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.3 | 1.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 1.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 1.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 1.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 1.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 1.7 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.5 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 0.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 1.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 2.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.2 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 1.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 2.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 1.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 1.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.2 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 1.9 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 1.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.4 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 0.4 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.0 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 1.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 1.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 3.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 1.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 1.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.2 | 0.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 1.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 1.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.4 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.6 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 0.2 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.2 | 0.4 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.2 | 2.4 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.6 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.2 | 0.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 1.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.4 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 1.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.9 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 1.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 2.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.7 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.2 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.2 | 0.3 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 3.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.0 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.8 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 1.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 1.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.2 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.2 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 1.3 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 0.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 1.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.3 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 0.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.8 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.2 | 0.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.2 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.6 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.5 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 1.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.3 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.6 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 0.2 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) |
0.1 | 2.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 2.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 0.3 | GO:2001269 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 2.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 3.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 1.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 1.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.7 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 2.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.7 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 1.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 4.2 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 2.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 5.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.6 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 5.3 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 2.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 2.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 0.1 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 1.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 1.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.5 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 1.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.1 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.3 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.9 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.8 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.8 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.1 | GO:0045623 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.7 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.9 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.4 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 1.1 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 17.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 4.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.4 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 0.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 1.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 2.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 3.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 6.1 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 3.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 2.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.5 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 1.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 1.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.1 | 1.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.8 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.9 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 1.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.3 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.2 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 3.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.9 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.7 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.1 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 1.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 2.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 1.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 1.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 2.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 2.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.3 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.3 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.8 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.3 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 1.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.5 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.2 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 3.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.8 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 0.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.1 | 0.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.1 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.3 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.1 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.1 | 0.8 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 2.1 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.6 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.1 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.3 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 2.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.5 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 2.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.6 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 4.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.1 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 2.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 2.6 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 1.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0032402 | melanosome transport(GO:0032402) |
0.1 | 0.2 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.8 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.1 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.3 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.1 | 0.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.3 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.9 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.1 | 0.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 1.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 2.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 3.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0071870 | cellular response to catecholamine stimulus(GO:0071870) |
0.1 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 2.1 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.5 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.7 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.4 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.1 | 0.3 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.1 | 0.1 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.2 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.3 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 1.1 | GO:0046323 | glucose import(GO:0046323) |
0.0 | 0.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.7 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 1.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 1.3 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.0 | 0.4 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.2 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.1 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.3 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.2 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.0 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0070814 | hydrogen sulfide metabolic process(GO:0070813) hydrogen sulfide biosynthetic process(GO:0070814) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.4 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.0 | GO:0009624 | defense response to nematode(GO:0002215) response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0032799 | regulation of low-density lipoprotein particle clearance(GO:0010988) low-density lipoprotein receptor particle metabolic process(GO:0032799) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 6.7 | GO:0006816 | calcium ion transport(GO:0006816) |
0.0 | 0.3 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 1.1 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.0 | 0.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 1.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.7 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:0035610 | protein deglutamylation(GO:0035608) protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 1.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.0 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.0 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 1.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.5 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 1.5 | GO:0032147 | activation of protein kinase activity(GO:0032147) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.0 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.0 | 1.0 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.0 | 0.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.3 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.8 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.0 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.0 | 0.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.5 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:2000677 | regulation of transcription regulatory region DNA binding(GO:2000677) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0036166 | phenotypic switching(GO:0036166) cellular response to cocaine(GO:0071314) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.5 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.1 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.0 | 0.0 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 0.1 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.6 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.0 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.0 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.1 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.0 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.0 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.3 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.1 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.0 | 0.2 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.0 | 0.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:0090670 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.0 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.0 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.0 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.0 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.0 | 0.0 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.0 | 0.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.0 | GO:0071599 | otic vesicle development(GO:0071599) |
0.0 | 0.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.0 | 0.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.0 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.3 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.0 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.0 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.0 | GO:0015871 | choline transport(GO:0015871) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 20.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.1 | 9.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.9 | 25.9 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
2.4 | 9.4 | GO:0042825 | TAP complex(GO:0042825) |
2.2 | 8.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.5 | 4.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.5 | 10.3 | GO:0042382 | paraspeckles(GO:0042382) |
1.3 | 6.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 3.4 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 7.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 3.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.9 | 33.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.8 | 2.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.8 | 4.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.7 | 2.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 2.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.7 | 3.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.6 | 1.8 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 2.3 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 3.7 | GO:0032009 | early phagosome(GO:0032009) |
0.5 | 2.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.5 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 2.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 2.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 0.4 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.4 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 5.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 25.2 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 1.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 2.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 20.8 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 4.1 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 0.9 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 5.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 2.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 1.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 6.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 1.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 4.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 3.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 2.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 8.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 8.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 3.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 5.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 9.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 15.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 1.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 2.3 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 13.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.2 | 4.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 2.4 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 4.3 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 3.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 0.9 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 7.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 2.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 3.2 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 0.8 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 5.1 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 3.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 3.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 12.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 6.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 2.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 1.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.6 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 2.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 4.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 3.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 3.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.5 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 4.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 19.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 16.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 5.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 3.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 4.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 2.2 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 4.6 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 2.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.5 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 57.7 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 1.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.8 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 1.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 1.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 1.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 3.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 1.7 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 2.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 2.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 4.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 6.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 1.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 3.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 2.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 102.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.0 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 1.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.0 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.0 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.1 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 10.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.1 | 9.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.8 | 8.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
2.6 | 15.9 | GO:0016936 | galactoside binding(GO:0016936) |
2.5 | 10.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.4 | 16.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.1 | 8.6 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
2.1 | 8.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
2.0 | 30.2 | GO:0005521 | lamin binding(GO:0005521) |
1.7 | 5.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.6 | 4.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.5 | 16.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.5 | 5.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.4 | 10.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.4 | 4.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.3 | 6.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.2 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.2 | 6.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.2 | 3.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.1 | 2.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.1 | 9.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.1 | 4.3 | GO:0015265 | urea channel activity(GO:0015265) |
1.0 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.0 | 7.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.0 | 2.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 10.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.9 | 7.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.9 | 6.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.8 | 3.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 2.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 1.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.8 | 2.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 2.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.7 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.7 | 2.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 2.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.7 | 5.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 12.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.7 | 2.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 1.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.7 | 2.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 2.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 8.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 1.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.6 | 2.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.6 | 4.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 2.2 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.5 | 2.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 2.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 2.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 1.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.0 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 2.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 8.0 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 2.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 2.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 2.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 5.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 1.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 3.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.4 | 1.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 7.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 6.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 2.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 3.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 6.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 4.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 7.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 3.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 1.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 1.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 1.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 4.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 1.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 1.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 7.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 3.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 10.3 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 6.0 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 4.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 13.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 7.2 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 2.9 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 1.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 3.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 3.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 1.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.2 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 2.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 1.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 1.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 2.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 0.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 10.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.8 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.8 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 2.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 0.5 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.3 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 3.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 3.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 3.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 1.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 1.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 33.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.4 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 6.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 7.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 4.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 2.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 5.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.6 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 1.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 1.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 2.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 2.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 6.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 31.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 0.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 3.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 1.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 9.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 2.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 4.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 4.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 4.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 1.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 54.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 1.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.8 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.2 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.3 | GO:0043759 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 4.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 4.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 11.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 4.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 2.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 2.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 2.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 1.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 2.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 3.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 3.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 2.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 1.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 7.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 2.0 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.1 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 4.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 1.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 1.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 1.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 1.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 2.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 6.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 6.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0070568 | mannose-phosphate guanylyltransferase activity(GO:0008905) guanylyltransferase activity(GO:0070568) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.5 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.7 | GO:0034944 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 2.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.6 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.4 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 0.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 1.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 2.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.8 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.8 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.1 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 3.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 1.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 3.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 3.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 1.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 1.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 1.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 4.4 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 3.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 7.2 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0034808 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 3.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.1 | GO:0034416 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 2.0 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 1.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 1.2 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.0 | 1.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 1.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 2.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 2.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.2 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.3 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 2.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.6 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 4.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.7 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 18.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 2.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.6 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.0 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.0 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0046790 | virion binding(GO:0046790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 8.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.9 | 13.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 5.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.7 | 4.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.7 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 28.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 11.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 30.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 9.2 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 16.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 2.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.4 | 3.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 3.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 1.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 2.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 2.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 9.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 6.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 5.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 8.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 12.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 9.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 8.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 1.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 3.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 2.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 2.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 2.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 6.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 3.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 3.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 5.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 2.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 9.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 121.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.1 | 22.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.7 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
1.2 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.9 | 16.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.7 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.7 | 5.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 6.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 6.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 6.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 1.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 4.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 9.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 1.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 1.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 1.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 3.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 4.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 6.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 4.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 14.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 1.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 13.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 3.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 3.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 3.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.3 | 1.1 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.3 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 5.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 6.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 1.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 5.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 3.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 3.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 3.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 4.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 4.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 6.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 3.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 2.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 2.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 5.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 3.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 2.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 3.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 3.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 3.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 2.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.3 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 1.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 5.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.1 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 1.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 12.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.7 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.1 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 0.9 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 3.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 2.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 3.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 2.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 1.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |